when it's okay to combine renin-angiotensin system blockers...ACEIs, ARBs, or aliskiren (Tekturna, etc)
February 2012
See the FDA's April 2012 safety notice concerning the use of Aliskiren (Tekturna) with ACEIs or ARBs
Some experts hoped that combining these would improve outcomes.
But there's growing evidence that these combos usually don't provide any additional benefit...and are sometimes harmful.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote